Testing effectiveness (Phase 2)Study completedNCT00476190What this trial is testingALL Adult Consortium Trial: Adult ALL TrialWho this might be right forAcute Lymphoblastic Leukemia Dana-Farber Cancer Institute 112
Not applicableStudy completedNCT00004875What this trial is testingHeparin or Enoxaparin in Patients With CancerWho this might be right forLymphomaThromboembolismUnspecified Adult Solid Tumor, Protocol Specific Northwestern University 6
Testing effectiveness (Phase 2)Study completedNCT01109264What this trial is testingBendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Jiangsu Simcere Pharmaceutical Co., Ltd. 147
Early research (Phase 1)Looking for participantsNCT05857969What this trial is testingEx Vivo Drug Sensitivity Testing and Multi-Omics ProfilingWho this might be right forRecurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+15 more Florida International University 65
Testing effectiveness (Phase 2)WithdrawnNCT02371590What this trial is testingLenalidomide and Obinutuzumab for Previously Untreated CLLWho this might be right forChronic Lymphocytic Leukemia University of California, San Diego
Not applicableNot Yet RecruitingNCT07597590What this trial is testingDigital Patient-Reported Assessment in Older Adults With Acute LeukemiaWho this might be right forLeukemia Acute MyeloidLeukemia Acute Lymphoid Leukemia (ALL) Fundación para la Investigación Biosanitaria del Principado de Asturias 20
Testing effectiveness (Phase 2)Ended earlyNCT01403246What this trial is testingChlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 9
Testing effectiveness (Phase 2)Study completedNCT00565981What this trial is testingA Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of ResponseWho this might be right forB-cell Chronic Lymphocytic Leukemia Arbeitsgemeinschaft medikamentoese Tumortherapie 10
Testing effectiveness (Phase 2)UnknownNCT01883219What this trial is testingTKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaWho this might be right forPhiladelphia Chromosome Positive Acute Lymphocytic LeukemiaStem Cell TransplantationMinimal Residual Disease Nanfang Hospital, Southern Medical University 80
Not applicableStudy completedNCT06655181What this trial is testingEvaluating the Effectiveness of Respiratory Muscle Training in Pediatric Kidney Transplant PatientWho this might be right forChronic Kidney Disease(CKD)Pediatric ALLPediatric Kidney Transplantation+1 more Atlas University 30
Large-scale testing (Phase 3)UnknownNCT04446130What this trial is testingStudy of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers PatientsWho this might be right forInduction ChemotherapyAcute T-Lymphocytic LeukemiaT-cell Lymphoblastic Lymphoma Leukemia+1 more The First Affiliated Hospital of Soochow University 100
Not applicableLooking for participantsNCT02682667What this trial is testingBiospecimen Procurement for Center for Immuno-Oncology Immunotherapy ProtocolsWho this might be right forMultiple MyelomaLymphoma, Non-HodgkinLeukemia-Lymphoma, Adult T-Cell+2 more National Cancer Institute (NCI) 500
Very early researchUnknownNCT06277011What this trial is testingSafety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical ResearchWho this might be right forAcute Lymphoblastic LeukemiaNon-hodgkin Lymphoma Anhui Provincial Hospital 18
Early research (Phase 1)Active Not RecruitingNCT02159495What this trial is testingGenetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell NeoplasmWho this might be right forAdult Acute Myeloid Leukemia in RemissionAcute Biphenotypic LeukemiaEarly Relapse of Acute Myeloid Leukemia+10 more City of Hope Medical Center 31
Early research (Phase 1)Study completedNCT00646139What this trial is testingKX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to TreatmentWho this might be right forLymphomaLymphoproliferative DisorderSmall Intestine Cancer+1 more Roswell Park Cancer Institute 7
Testing effectiveness (Phase 2)Study completedNCT04969601What this trial is testingAnti-Covid-19 Vaccine in Children With Acute Leukemia and Their SiblingsWho this might be right forAcute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia Assistance Publique - Hôpitaux de Paris 76
Not applicableUnknownNCT03564977What this trial is testingCD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell TransplantationWho this might be right forLymphoma, B-CellLeukemia, B-CellMinimal Disease, Residual Qingdao Central Hospital 20
Not applicableTemporarily pausedNCT07313592What this trial is testingWhole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) PatientsWho this might be right forAcute Lymphoblastic Leukemia Washington University School of Medicine 60
Testing effectiveness (Phase 2)Study completedNCT01251575What this trial is testingSirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forAdult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more Fred Hutchinson Cancer Center 77
Early research (Phase 1)Ended earlyNCT00376519What this trial is testingUmbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Masonic Cancer Center, University of Minnesota 3